Pfizer has achieved single digit growth in sales and net profit during the first quarter ended February 2010. Its net sales increased by 9 per cent to Rs 202.61 crore from Rs 185.97 crore in the corresponding period of last year. For the full year ended November 2009, Pfizer recorded net sales of Rs 772.27 crore. Its pharmaceutical sales improved by 9 per cent to Rs 172.64 crore from Rs 158.32 crore and that of animal health went up 8.2 per cent to Rs 29.97 crore from Rs 27.69 crore in the last period.
The net profit during the quarter under review increased by 8.8 per cent to Rs 42.45 crore from Rs 39.01 crore in the similar period of last year. The EBDIT improved by 8.1 per cent to Rs 67.21 crore from Rs 62.17 crore. For the full year ended November 2009, Pfizer's net profit amounted to Rs 136.88 crore.
Pfizer Investments Netherlands B V and Pfizer Inc announced an open offer to acquire up to 100.78 lakh shares of the company on June 10, 2009. Of the total of 211.13 lakh shares disclosed as promoters and promoter group shareholding, 88.10 lakh shares represent the shares tendered in the open offer. Out of these shares tendered, 87.82 lakh shares are currently held in the escrow account for the benefit of Pfizer Investments Netherlands B V and same will be transfer on completion of all formalities. .
The company amalgamated Duchem Laboratories Ltd with effect from December 1, 2008 and figures for same are not included in the quarter ended February 28, 2009.